Countries

Dalbavancin

TypeName: Business Offer
Request Date:2017/09/26
Country: United States
Summary: Dalbavancin (INN, trade name Dalvance) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin.The Food and Drug Administration approved dalbavancin for the treatment of acute bacterial skin and skin structure infections caused by certain susceptible bacteria.http://www.creative-peptides.com/product/dalbavancin-item-10-101-78-32.html
Description:
Advantages:
Comments:
RequestId: 504
Name:Cathy Miller
Telphone:
Email:contact@creative-peptides.com
United States